ロード中...
A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial(†)
AIMS: Clinical trials suggest that intracoronary delivery of autologous bone marrow-derived cells (BMCs) 1–7 days post-acute myocardial infarction (AMI) may improve left ventricular (LV) function. Earlier time points have not been evaluated. We sought to determine the effect of intracoronary autolog...
保存先:
| 出版年: | Eur Heart J |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4712349/ https://ncbi.nlm.nih.gov/pubmed/26405233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv493 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|